US 12,143,386 B2
Diabetes management partner interface for wireless communication of analyte data
Apurv Ullas Kamath, San Diego, CA (US); Michael Robert Mensinger, San Diego, CA (US); Nicholas Polytaridis, San Diego, CA (US); Gary A. Morris, San Diego, CA (US); Alexandra Elena Constantin, San Jose, CA (US); Douglas William Burnette, San Diego, CA (US); Mario Remon, Ft. Lauderdale, FL (US); Jorge R. Barreras, Miami, FL (US); Benjamin Elrod West, San Diego, CA (US); and Christopher Robert Hannemann, San Diego, CA (US)
Assigned to Dexcom, Inc., San Diego, CA (US)
Filed by Dexcom, Inc., San Diego, CA (US)
Filed on Oct. 10, 2023, as Appl. No. 18/484,256.
Application 18/484,256 is a continuation of application No. 17/661,739, filed on May 2, 2022, granted, now 11,818,133.
Application 17/661,739 is a continuation of application No. 16/169,886, filed on Oct. 24, 2018, granted, now 11,363,025, issued on Jun. 14, 2022.
Application 16/169,886 is a continuation of application No. 16/169,661, filed on Oct. 24, 2018, granted, now 11,153,317, issued on Oct. 19, 2021.
Claims priority of provisional application 62/579,061, filed on Oct. 30, 2017.
Prior Publication US 2024/0039921 A1, Feb. 1, 2024
Int. Cl. H04L 9/40 (2022.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); G16H 10/60 (2018.01); G16H 10/65 (2018.01); G16H 40/40 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); H04W 12/06 (2021.01); H04W 52/02 (2009.01); H04W 76/14 (2018.01); A61B 5/1495 (2006.01); H04W 4/38 (2018.01); H04W 4/80 (2018.01)
CPC H04L 63/101 (2013.01) [A61B 5/14532 (2013.01); A61B 5/686 (2013.01); G16H 10/60 (2018.01); G16H 10/65 (2018.01); G16H 50/20 (2018.01); H04W 12/06 (2013.01); H04W 52/0277 (2013.01); H04W 76/14 (2018.02); A61B 5/0002 (2013.01); A61B 5/0004 (2013.01); A61B 5/14503 (2013.01); A61B 5/14546 (2013.01); A61B 5/1495 (2013.01); A61B 5/486 (2013.01); A61B 5/7445 (2013.01); A61B 5/746 (2013.01); H04L 2209/88 (2013.01); H04W 4/38 (2018.02); H04W 4/80 (2018.02)] 17 Claims
OG exemplary drawing
 
1. A system comprising:
a display device and a partner device, the display device configured to provide information regarding analyte values in a user's body and in wireless communication with an analyte sensor system and the partner device, wherein the partner device is an insulin delivery device and is not directly connected to the analyte sensor system, and wherein:
the display device receives analyte data from the analyte sensor system;
the partner device delivers insulin to a user based on analyte data generated using the analyte sensor system, or data derived therefrom, that is received from the display device;
the display device alerts the user and provides analyte data received from the analyte sensor system; and
the display device provides information relating to delivery of insulin by the partner device.